Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

MHLWRegulator guidanceDossier formatMedicinesHigh confidenceLast verified October 5, 2026

JP notification on electronic study data (2024)

Notification on Handling of Submission of Electronic Study Data for New Drug Applications

Current edition

Notification of April 8, 2024

About this standard

Requires clinical study data for new drug applications to be sent to the agency in electronic form, and says which products and data are covered.

Recognition by market

Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts

No market listing is published yet.

Testing requirements that cite it

Open the market page and its pathway pages for the full requirement, protocol and report content

Japan

Related standards: FDA eCTD submission guidance, MDR 2017 Fourth Schedule, Appendix II and III, M4(R4), M4Q(R1), M4Q(R2), M4S(R2), M4E(R2), ACTD, CDSCO Guidance for Industry (Biologicals), COFEPRIS CTD guide v3.0, DS-G-003, DS-REQ-002. See all standards.

Not legal or regulatory advice. Check the current official rules before you act. Parts of the approvals data are official open data reused under open licences. Data sources.

LinkedInLinkedInXXYouTubeYouTube